To kick off our new season, we’re joined by Joseph Peterson, co-founder of Simbiosys, a company that’s breaking new ground in precision cancer care.

Personalized care is the future, especially for cancer care, and Simbiosys' use of computational modeling and digital twins is one to watch.

Joe’s journey is really impressive - from pouring silanes into concrete as a novice mason to now building digital replicas of tumors to guide life-saving treatment decisions.

We discuss -

•  How Joe's fascination with physical materials evolved into a passion for biology, supercomputing, and ultimately, transforming how breast cancer is diagnosed and treated.
• Product strategy, clinical impact, AI in the OR, and the unglamorous truths of real-world implementation.
• All things digital twins in cancer care and beyond
• The startup's journey from concept to FDA engagement
• Building credibility in a high-stakes clinical space
• How to balance scientific depth with startup speed

If you're curious about the future of personalized cancer care - or what construction and oncology have in common! - this one's for you.

https://www.linkedin.com/in/charlie-webb-a5605768/
https://www.linkedin.com/in/sumair-gill-086a151a1/